Ellutia showcasing fully automated total nitrosamine testing system at Lab Innovations 2022
At Lab Innovations 2022, Ellutia will present the newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA). The fully automated solution allows for rapid testing of apparent total nitrosamine content (ATNC) and has the right selectivity and sensitivity, so it can quickly identify whether or not nitrosamines are present down to 1ppb levels.
Ubiquigent obtains exclusive license for UbiSite technology to strengthen its specialist drug discovery services
Dundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitylase (DUB) modulators as new therapeutics for areas of high unmet medical need, has signed an exclusive license with the University of Southern Denmark for its UbiSite® technology.
Innovate UK EDGE prepares biotech client Bilitech for Investment
Bilitech Ltd a SME based in Cambridge has developed a technology to manufacture bioengineered bile ducts in the laboratory and aims to translate it to the clinic for use in patients. Bilitech specialises in the treatment of biliary disease, focusing on the use of bioengineered bile ducts.
Nuclera Nucleics Ltd grows and scale with support from Innovate UK EDGE support
With support from Innovate UK EDGE, biotech company Nuclera Nucleics were able to create a commercialisation plan, secured Series B funding and are on track to double their headcount by the end of 2022.
Wear it Pink!
Last week Corazon Health took part in 'Wear It Pink' event to raise much needed funds for Breast Cancer Now to help make life-saving breast cancer research and vital support happen.
Hospital charity’s surgical robot appeal reaches £1.5m target
Thousands more patients at Addenbrooke’s Hospital will benefit from the advantages of robotic surgery thanks to the support of local people who’ve helped raised £1.5 million to buy the hospital a new robot.
Cresset's October 2022 Newsletter
Read about Cresset's latest case studies, published papers, and upcoming events
Cambridge Filmworks produce a suite of new films for Genomics England
Genomics England mission is to turn science into healthcare, using technology – for everyone. They handle the huge quantities of data produced by genomic sequencing in the NHS, to improve patient treatment and empower research into new therapeutic discoveries. The Genomics England team is motivated by the challenge of the task, the desire to learn and by each other.
Addenbrooke’s Charitable Trust appoints new Chair of Trustees
The Board of Trustees at ACT has appointed a new Chair to lead the charity’s governance.
Sphere Fluidics opens new laboratory facilities at Granta Park in Cambridgeshire, UK
Cambridge, UK - Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announces that it has opened a new state-of-the-art facility in Granta Park, Cambridgeshire, UK, to support the Company’s growth. Doubling overall capacity, the laboratories enable the team’s accelerated expansion, and the development of new, innovative products.
Can mRNA bring its magic to seasonal influenza vaccines?
This month VacZine Analytics, a UK-based strategic research publisher exclusively focused on vaccines and infectious diseases, releases a brand-new global forecast of seasonal influenza vaccines, and discusses the prospects for new mRNA candidates.
Cash in the cupboard: UK consumers hoard a billion pounds’ worth of old smartphones
An estimated 24 million smartphones were kept as spare by UK consumers over the last three years, with a collective value of over £1 billion; Deloitte’s Digital Consumer Trends survey of 4,160 consumers found that two in five phone buyers hold on to their unused phones; In 2022 alone, seven million smartphones, worth over £500 million, will be retained as people upgrade to newer models…
AudioTelligence wins Innovator Award
AudioTelligence's aiso for hearing software has won a Hearing Technology Innovator Award. The groundbreaking assistive technology won in the Personal Amplification: Software category in the annual Hearing Health and Technology Matters awards. These awards recognise technological innovation and achievement in the hearing industry.
Ubiquigent appoints Dr Sheelagh Frame, CSO, to its Board of Directors
New Board appointment supports Ubiquigent’s pursuit of novel DUB modulators as new therapeutics to address areas of high unmet medical need
Communication misfires at work ruined your day?
Career Ambitions says:
Tell me if this sounds familiar.
Smart moves: how understanding human behaviour helps organisations deliver bigger impact
How can investing time revealing human behaviours and actions lead to more straightforward, less resource-hungry, longer-lasting impact? An upcoming webinar for leaders of change, operations, L&D, employee engagement and internal comms will explore how to target your effort and resources where they’ll make the most difference.
Gosforth mum and team raise thousands of pounds to support children’s brain tumour charity in Great North Run
A dedicated mum from Gosforth has helped to raise thousands of pounds for the charity which helped her family after her son was diagnosed with a brain tumour.
Royal Society of Chemistry Horizon Prizes - celebrating discoveries and innovations
Chemistry is at the centre of everything you can see, smell, touch and taste.
Whether studying the chemistry of life, or developing the advanced science behind modern technology, chemical scientists use their expertise to improve our health, our environment and our daily lives.
10 ways you can help to Buy Addenbrooke’s a Robot
We have almost reached our £1.5m target to buy a surgical robot for Addenbrooke's and are calling on our supporters to help us over the finish line. What could YOU do to support your hospital?
FUJIFILM Irvine Scientific PRIME-XV Stem FreezIS DMSO-Free Cryopreservation Medium to be used in FDA-authorized clinical trial
SANTA ANA, Calif., - FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, announces that its PRIME-XV Stem FreezIS DMSO-Free* cryopreservation medium is to be used as an excipient in a FDA-authorized clinical trial conducted by Vitro Biopharma.
Model Making: an insider’s guide (part 2)
Project roadmap
The term ‘model making’ covers many different things, as models can be required to perform a wide variety of roles.
Model Making: an insider’s guide (part 1)
Prototype Projects Ltd says: This article is the first of a two-part series in which we will tell you everything you need to know about model making. While this first part explains what professional model making is, when it is useful and what it can achieve, the second part delves into the nitty-gritty of the workflow and technologies.
6 ways to overcome Imposter Syndrome
"I can't believe I got the job, they must be desperate."
"I'm not good enough."
"I wasn't very good. They will realise soon and get rid of me."
"I don't think I know what I am talking about."
Local health and care champion seeks new leader
Healthwatch Cambridgeshire and Peterborough CIC are on the hunt for a new CEO after leader, Sandie Smith, announces she will be stepping down in March 2023, after ten years at the helm.
Sanger researcher elected to U.S. National Academy Of Medicine
The Sanger Institute’s Dr Peter Campbell has been elected to the U.S National Academy of Medicine, in recognition of his contribution to the field of cancer genomics. Dr Campbell is Head of the Institute’s Cancer, Ageing and Somatic Mutation programme, having joined Sanger as a post-doctoral fellow in 2007.